We next compared the correlations between IL-6 expression, MDSCs infiltration, other clinical pathological features (age, agenda, tumor size, tumor pathologic stage, tumor histological grade, and lymph node invasion), and expression of hormone receptors (estrogen receptor, progesterone receptor, and HER2) in the two cohorts. This evidence concerns the gene ERBB2 and neoplasm.